{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:12:12Z","timestamp":1783163532639,"version":"3.54.6"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.exphem.2025.105333","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T08:01:16Z","timestamp":1764403276000},"page":"105333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Germline heterozygous SH2B3 p.Glu78Lys variant: a three-patient case series with myeloproliferative neoplasms"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6616-5884","authenticated-orcid":false,"given":"Giovanni","family":"Iaquinta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9432-224X","authenticated-orcid":false,"given":"Alessandro","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tamburini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Tatarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1355-1587","authenticated-orcid":false,"given":"Patrizia","family":"Chiusolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ragazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Savino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Breccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Grammatico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2025.105333_bib0001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ph15010024","article-title":"The role of LNK (SH2B3) in the regulation of JAK-STAT signalling in haematopoiesis","volume":"15","author":"Morris","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.exphem.2025.105333_bib0002","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20040762","article-title":"LNK inhibits Tpo-MPL signaling and Tpo-mediated megakaryocytopoiesis","volume":"200","author":"Tong","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2025.105333_bib0003","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1182\/blood-2004-10-4093","article-title":"LNK inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways","volume":"105","author":"Tong","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105333_bib0004","first-page":"2832","article-title":"LNK controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2","volume":"118","author":"Bersenev","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2025.105333_bib0005","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1038\/s41467-021-26394-6","article-title":"Structural and functional analysis of target recognition by the lymphocyte adaptor protein LNK","volume":"12","author":"Morris","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2025.105333_bib0006","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/leu.2017.139","article-title":"The role of LNK\/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders","volume":"31","author":"Maslah","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.105333_bib0007","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41586-020-2430-6","article-title":"Monogenic and polygenic inheritance become instruments for clonal selection","volume":"584","author":"Loh","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.105333_bib0008","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ajh.24259","article-title":"LNK mutations and myeloproliferative disorders","volume":"91","author":"McMullin","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2025.105333_bib0009","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1189\/jlb.0908575","article-title":"LNK inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F","volume":"85","author":"Gery","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.exphem.2025.105333_bib0010","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/leu.2010.163","article-title":"LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPLmutations","volume":"24","author":"Pardanani","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.105333_bib0011","first-page":"2542","article-title":"Germline bi-allelic SH2B3\/LNK alteration predisposes to a neonatal juvenile myelomonocytic leukemia-like disorder","volume":"109","author":"Arfeuille","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.105333_bib0012","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41431-025-01877-y","article-title":"Biallelic SH2B3 germline variants are associated with a neonatal myeloproliferative disease and multisystemic involvement","volume":"33","author":"Leardini","year":"2025","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.exphem.2025.105333_bib0013","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3324\/haematol.2016.144063","article-title":"Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations","volume":"101","author":"Camps","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.105333_bib0014","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jmoldx.2016.05.006","article-title":"Rapid molecular profiling of myeloproliferative neoplasms using targeted exon resequencing of 86 genes involved in JAK-STAT Signaling and epigenetic regulation","volume":"18","author":"Magor","year":"2016","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.exphem.2025.105333_bib0015","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1182\/blood-2012-11-465138","article-title":"Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations","volume":"121","author":"Neumann","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105333_bib0016","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2024-210339","article-title":"SH2B3 loss of function variants are potential drivers of severe thrombocytosis","volume":"144","author":"Awan-Toor","year":"2024","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25006228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25006228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:28:52Z","timestamp":1768566532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X25006228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":16,"alternative-id":["S0301472X25006228"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2025.105333","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline heterozygous SH2B3 p.Glu78Lys variant: a three-patient case series with myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2025.105333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Experimental Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105333"}}